ROSELABS FINANCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.1 INR | +0.33% |
|
-0.66% | +40.13% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 220.5 | 142.5 | 117.4 | 309.5 | 163.8 | 144.9 |
| Enterprise Value (EV) 1 | 289.7 | 183.2 | 162.2 | 354.7 | 212.8 | 188.1 |
| P/E ratio | 851 x | -36.5 x | -83.9 x | -12 x | -37.2 x | 7.19 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 7.28 x | - | - | - | - | - |
| EV / Revenue | 9.56 x | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / FCF | 3.3 x | 67.6 x | -40.7 x | 25.1 x | -98.6 x | -10 x |
| FCF Yield | 30.3% | 1.48% | -2.46% | 3.98% | -1.01% | -9.96% |
| Price to Book | -7.91 x | -4.49 x | -3.55 x | -5.26 x | -2.59 x | -3.37 x |
| Nbr of stocks (in thousands) | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
| Reference price 2 | 22.05 | 14.25 | 11.74 | 30.95 | 16.38 | 14.49 |
| Announcement Date | 9/27/18 | 8/29/19 | 9/4/20 | 8/27/21 | 9/1/22 | 7/25/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 30.31 | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | 2.766 | -2.645 | -1.378 | -1.573 | -4.377 | -6.18 |
| Operating Margin | 9.13% | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | 0.433 | -4.165 | -1.355 | -27.47 | -4.377 | 20.63 |
| Net income 1 | 0.259 | -3.888 | -1.355 | -25.73 | -4.366 | 20.16 |
| Net margin | 0.85% | - | - | - | - | - |
| EPS 2 | 0.0259 | -0.3900 | -0.1400 | -2.573 | -0.4400 | 2.016 |
| Free Cash Flow 1 | 87.73 | 2.711 | -3.989 | 14.12 | -2.158 | -18.73 |
| FCF margin | 289.48% | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | 33,872.44% | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/27/18 | 8/29/19 | 9/4/20 | 8/27/21 | 9/1/22 | 7/25/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 69.2 | 40.7 | 44.8 | 45.2 | 49 | 43.2 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 87.7 | 2.71 | -3.99 | 14.1 | -2.16 | -18.7 |
| ROE (net income / shareholders' equity) | -0.93% | 13% | 4.18% | 56% | 7.16% | -38% |
| ROA (Net income/ Total Assets) | 0.95% | -3.96% | -7.12% | -14.1% | -141% | -260% |
| Assets 1 | 27.17 | 98.2 | 19.03 | 183 | 3.103 | -7.745 |
| Book Value Per Share 2 | -2.790 | -3.180 | -3.310 | -5.880 | -6.320 | -4.300 |
| Cash Flow per Share 2 | 0.4600 | 0.0100 | 0.0100 | 0.0500 | 0.0300 | 0 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 9/27/18 | 8/29/19 | 9/4/20 | 8/27/21 | 9/1/22 | 7/25/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +40.13% | 3.61M | |
| -6.19% | 26.35B | |
| -8.51% | 18.19B | |
| -23.96% | 10.28B | |
| -16.46% | 9.84B | |
| -3.37% | 8.67B | |
| -4.57% | 6.73B | |
| -11.93% | 5.42B | |
| +32.17% | 4.39B | |
| -10.00% | 2.23B |
- Stock Market
- Equities
- ROSELABS6 Stock
- Financials Roselabs Finance Limited
